Skip Ribbon Commands
Skip to main content
Menu

Pharma RFP/Invitation Notices

Terms and Conditions: 

  1. All RFP proposals must be submitted through the Ariba sourcing tool.
  2. Your company must be registered in Singapore to participate in ALPS events.
  3. For all events, the Supply Head requirement for participation is EPU/DAP/32.
  4. Each Company must participate at all sourcing events through or using the same Ariba account. 

You can gain direct access into events by following the steps outlined below:
  • Click on the respective link found in the column “Respond to Posting”. You will be directed to the next page
  • Click on the “Respond to Posting” button found on the page
  • Log in to Ariba by entering your Ariba ID and password
  • You will gain access into the event for proposal submission
  • Submit your proposal in the Ariba sourcing tool before the closing date and time stated in the RFP notice below ​ 

Contact Persons:

Alicia Chua (Tel: 6377 8728)
Genesis Lim (Tel: 6377 8737)
Nadiah (Tel: 6377 8734)

Purchasing Programme

Evaluation Criteria

Evaluation Criteria (Unregistered Drugs)

RFP Results (Updated on 17 April 2025)

Estimated Annual Quantities


RFP/Invitation Notices
RFP NoUse SHIFT+ENTER to open the menu (new window).
  
Event Description
RFP DocumentUse SHIFT+ENTER to open the menu (new window).
  
Published DateUse SHIFT+ENTER to open the menu (new window).
  
Closing Date/timeUse SHIFT+ENTER to open the menu (new window).
  
Respond to PostingUse SHIFT+ENTER to open the menu (new window).
  
Financial CategoryUse SHIFT+ENTER to open the menu (new window).
  
CorrigendumUse SHIFT+ENTER to open the menu (new window).
  
Remarks
GPOR 06025
Item 1 - Sodium Chloride 0.9% w/v Injection, 10ml pre-filled syringe
Item 2 - Vasopressin 20 units/mL Injection, 1mL vial


GPOR 0602511/04/20252/5/2025 12:00 PMhttps://discovery.ariba.com/rfx/22982801S4 or higherNo
GPOR 05825

​Item 1 - Dipyridamole 10mg/2mL Injection 2mL

GPOR 0582504/04/202525/4/2025 12:00 PMhttps://discovery.ariba.com/rfx/22927443S4 or HigherNo
GPOR 05725

​Item 1 - Terazosin 1mg Tablets

GPOR 0572504/04/202525/4/2025 12:00 PMhttps://discovery.ariba.com/rfx/22926636S4 or HigherNo
GPOR 05625
Item 1 - Pomalidomide 2mg Capsules
Item 2 - Pomalidomide 3mg Capsules
Item 3 - Pomalidomide 4mg Capsules

GPOR 0562504/04/202525/4/2025 12:00 PMhttps://discovery.ariba.com/rfx/22943469S6 or HigherNo
GPOR 05525

Item 1 - Risperidone 1mg/mL Oral Solution, 30mL bottle

GPOR 0552504/04/202525/4/2025 12:00 PMhttps://discovery.ariba.com/rfx/22926219S6 or HigherNo
GPOR 05425

Items 1 to 3 - Unregistered Drugs

GPOR 0542504/04/202525/4/2025 12:00 PMhttps://discovery.ariba.com/rfx/22905034S2 or HigherNo
GPOR 05325

Items 1 to 3 - Unregistered Drugs

GPOR 0532504/04/202525/4/2025 12:00 PMhttps://discovery.ariba.com/rfx/22898879S3 or HigherNo
GPOR 05225
Items 1 to 3 - Unregistered Drugs




GPOR 0522504/04/202525/4/2025 12:00 PMhttps://discovery.ariba.com/rfx/22898479S5 or HigherNo
GPOR 05125
Items 1 to 3 - Unregistered Drugs




GPOR 0512504/04/202525/4/2025 12:00 PMhttps://discovery.ariba.com/rfx/22898338S3 or HigherNo
GPOR 05025
Items 1 to 3 - Unregistered Drugs


GPOR 0502504/04/202525/4/2025 12:00 PMhttps://discovery.ariba.com/rfx/22897963S4 or HigherNo
GPOR 04925
Items 1 to 3 - Unregistered Drugs


GPOR 0492504/04/202525/4/2025 12:00 PMhttps://discovery.ariba.com/rfx/22897182S4 or HigherNo
GPOR 04825

​Item 1 - Trastuzumab 600mg/5mL Injection

GPOR 0482504/04/202525/4/2025 12:00 PMhttps://discovery.ariba.com/rfx/22943355S6 or HigherNo
GPOR 04725
Item 1 - Pazopanib 200mg Tablets
Item 2 - Pazopanib 400mg Tablets

GPOR 0472504/04/202525/4/2025 12:00 PMhttps://discovery.ariba.com/rfx/22943203S6 or HigherNo
GPOR 04625
Item 1 - Tocilizumab 200mg/10mL Injection, 10mL vial
Item 2 - Tocilizumab 400mg/20mL Injection, 20mL vial
Item 3 - Tocilizumab 80mg/4mL Injection, 4mL vial
GPOR 0462504/04/202525/4/2025 12:00 PMhttps://discovery.ariba.com/rfx/22928547S6 or HigherNo
GPOR 04525

​Item 1 - Dupilumab 300mg/2mL Injection, 2mL pre-filled syringe

GPOR 0452504/04/202525/4/2025 12:00 PMhttps://discovery.ariba.com/rfx/22928346S9 or HigherNo
GPOR 04425
Item 1 - Cytarabine 1,000mg/10mL Injection
Item 2 - Dacarbazine 200mg Injection

GPOR 0442504/04/202525/4/2025 12:00 PMhttps://discovery.ariba.com/rfx/22927665S3 or HigherNo
GPOR 04325
Item 1 - Tegafur 100mg and Uracil 224mg Capsules
Item 2 - Fluoxetine Hydrochloride 10mg Capsules
Item 3 - Imipramine Hydrochloride 25mg Tablets
GPOR 0432504/04/202525/4/2025 12:00 PMhttps://discovery.ariba.com/rfx/22904811S4 or HigherNo
GPOR 04225

​Item 1 - Clozapine 25mg Tablets

GPOR 0422504/04/202525/4/2025 12:00 PMhttps://discovery.ariba.com/rfx/22905548S5 or HigherNo
GPOR 04125

Item 1 - Haemophilus Type b Conjugate Vaccine, 0.5mL/pre-filled syringe

GPOR 0412504/04/202525/4/2025 12:00 PMhttps://discovery.ariba.com/rfx/22898079S2 or HigherNo
GPOR 04025

Item 1 - Yellow Fever Vaccine (Live), 1 dose/vial

GPOR 0402504/04/202525/4/2025 12:00 PMhttps://discovery.ariba.com/rfx/22897782S5 or HigherNo
GPOR 03925

Item 1 - Somatropin 10mg/1.5mL Injection, 1.5mL pre-filled pen

GPOR 0392504/04/202525/4/2025 12:00 PMhttps://discovery.ariba.com/rfx/22895206S5 or HigherNo

SingHealth Updates for Healthcare Professionals

HealthXchange E-news Subscription

Health Buddy App

About Us
Patient Care
Research
Education
Careers
Giving
SingHealth
SingHealth Duke-NUS
Address10 Hospital Boulevard, #19-01 SingHealth Tower. Singapore 168582Telephone+65 6225 0488
Award2Award3Award4Award5
© 2024 SingHealth Group. All Rights Reserved.

Best viewed on IE 11, Firefox 27, Chrome 22, and Safari 7 and above.